The largest database of trusted experimental protocols

Hek293t packaging cells

Manufactured by Thermo Fisher Scientific
Sourced in United States

HEK293T packaging cells are a type of human embryonic kidney (HEK) cell line that is commonly used for the production of lentiviral and retroviral vectors. These cells are genetically modified to efficiently package viral particles, making them a valuable tool for researchers in the field of gene delivery and gene therapy.

Automatically generated - may contain errors

4 protocols using hek293t packaging cells

1

Stable APC Knockdown Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
To knockdown APC expression and construct a stable cell line, pCDH-CMV-MCS-EF1-Puro (CD510B-1) shRNA vectors targeting human APC was purchased from Open Biosystems (Thermo Fisher Scientific, US). The sequences were based on the previous siRNA study. Lentiviral shRNA was produced by co-transfection of the trans- lentiviral packaging system by adding mixture of pCDH-CMV-MCS-EF1-Puro (CD510B-1)-shAPC and packaging plasmids pSPAX2 and pMD2.0G into HEK293T packaging cells (Open Biosystems, US). Viral supernatants were collected for cell infection, supplemented with 6 μg/mL polybrene. After 24 hours incubation, HCT116 and NCM460 were transduced by the lentiviral particles followed by puromycin selection (1.5μg/mL) for 7 days. The cells stably expressing shRNA were maintained in puromycin (0.75 μg/mL).
+ Open protocol
+ Expand
2

STMN1 Knockdown in Esophageal Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To knockdown STMN-1 expression, pGIPZ-lentiviral shRNAmir vectors targeting human STMN1 and Non-silencing pGIPZ control vector were purchased from Open Biosystems (Thermo Fisher Scientific, Inc.). The sequences of STMN-1 shRNA are as following: 5′-TTATTAGCTTCCATTTTGT-3′; 5′-TCTCTTCTATTGCCTTCTG-3′ and 5′-TTATTAACCATTCAAGTCC-3′. Lentiviral shRNA was produced by Co-transfection of the Trans-Lentiviral packaging mix with a shRNA transfer vector into HEK293T packaging cells (OpenBiosystems). For cell infection, viral supernatants were supplemented with 6 μg/mL polybrene and incubated with cells for 24 hours. Esophageal adenocarcinoma cell lines were transduced by the lentiviral particles followed by puromycin selection (1 μg/mL) for 10 days. The cells stably expressing shRNA were maintained in puromycin (0.2 μg/mL).
+ Open protocol
+ Expand
3

Lentiviral Knockdown of Nox4 in Glioma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
pGIPZ-lentiviral shRNAmir vectors targeting human Nox4 gene and nonsilencing pGIPZ control vector were purchased from Open Biosystems (Thermo Fisher Scientific, Inc.). pGIPZ cloning vector contains Turbo GFP reporter and expresses a puromycin-resistant gene. Lentiviral shRNA was produced by cotransfection of the Trans-Lentiviral Packaging Mix with a shRNA transfer vector into HEK 293T packaging cells (Open Biosystems). Supernatants containing either the lentivirus expressing the Nox4 shRNA or the control shRNA were harvested 72 h after transfection. The lentiviruses were purified using ultracentrifugation, and the titer of the lentiviruses was determined. U87MG and U251 cells were transduced by the lentiviral particles at a multiplicity of infection (MOI) of 10 followed by puromycin selection for 10 days. The clones stably transfected with pGIPZ-lentiviral shRNAmir was referred to as Nox4 shRNA cells, whereas the cells stably transfected with pGIPZ nonsilencing control vector as scrambled cells. The knockdown of Nox4 was evaluated by real-time quantitative PCR and Western blot analysis.
+ Open protocol
+ Expand
4

Lentiviral Silencing of MSI1 in D283 Med Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Silencing of MSI1 was performed using two different shRNA vectors (pLV[shRNA]-EGFP:T2A:Bsd-U6 > hMSI1[shRNA#1] and pLV[shRNA]-EGFP:T2A:Bsd-U6 > hMSI1[shRNA#2]), and their respective control (pLV[shRNA]-EGFP:T2A:Bsd-U6 > Scramble_shRNA#1) acquired from Vector Builder (https://en.vectorbuilder.com) containing a gene for blasticidin resistance. Plasmids were expanded in LB medium supplemented with 100µg/mL of Ampicillin; and purified using the QIAprep Spin Miniprep Kit protocol (Qiagen Company, Hilden, Germany, #Cat. 27104), following manufacturer's instructions. To analyze the yield and purity of the plasmids, the NanoDrop Spectrophotometer device (Thermo Scientific, DE, USA) was used. Lentiviral particles were produced by co-transfection of the trans-lentiviral packaging mix with a shRNA transfer vector into HEK 293T packaging cells (OpenBiosystems). For cell infection, viral supernatants were supplemented with 6µg/mL polybrene and incubated with cells for 24 hours. D283 Med transduced cells were selected with blasticidin (10 µg/mL) for 7 days.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!